Breathe Well Live Well
|
Enzyme revealed as promising target to treat asthma and cancer
EurekAlert (press release) In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain cancer therapies. |
View full post on asthma – Google News
|
Basic cancer research at Creighton yields promising results for diagnosing …
News-Medical.net What started as basic cancer research at Creighton University has yielded promising results for diagnosing and treating asthma – and the National Institutes of Health (NIH) agrees, investing nearly $1.5 million in Creighton to find out more. In a … |
View full post on asthma – Google News
|
A promising target to treat asthma
Science Daily (press release) July 24, 2013 — An enzyme known for its role in heart disease may well be a promising target to treat asthma. Researchers from the University of Iowa have found that the enzyme, called CaMKII, is linked to the harmful effects of oxidation in the … Enzyme May Allow Targeted Asthma Treatment, Researchers Say |
View full post on asthma – Google News
|
A promising target to treat asthma
Iowa Now An enzyme known for its role in heart disease may well be a promising target to treat asthma. Researchers from the University of Iowa have found that the enzyme, called CaMKII, is linked to the harmful effects of oxidation in the respiratory tract … |
View full post on asthma – Google News
|
Boehringer Ingelheim's tiotropium shows promising results in patients with …
News-Medical.net Boehringer Ingelheim today announced data from Phase 2 and Phase 3 studies from the Company's ongoing clinical trial program investigating the efficacy and safety of tiotropium in asthma. These data were presented at the American Thoracic Society … Phase III results: tiotropium* Respimat® effective in symptomatic asthma … Boehringer Ingelheim reports positive data from symptomatic asthma trials |
View full post on asthma – Google News
|
Health Watch: Promising 'Combo Inhaler' For Asthma Patients
CBS Local MINNEAPOLIS (WCCO) — Nine people die from asthma each day in the U.S. Now, a new study looks at patients who have trouble controlling their condition and suggests possibly changing the way doctors treat them. Currently, many asthma patients have … Study suggests new treatment methods for asthma sufferers NZ tech leads in treatment of asthma Studies support combined prevention and rescue asthma inhaler |
View full post on asthma – Google News
|
Promising Phase II Data For Tiotropium In Adolescent Asthma Patients
Science 2.0 [1] Boehringer Ingelheim announced that the company has a comprehensive confirmatory phase III trial programme named UniTinA-asthma(TM) ongoing to fully evaluate the potential of the long-acting bronchodilator in the treatment of asthma. |
View full post on asthma – Google News
|
Asthma And Allergies – HRF Molecule Is A Promising Target For Treatment
Medical News Today The histamine releasing factor (HRF) molecule has been identified by researchers at La Jolla Institute for Allergy & Immunology, as a potential target for developing novel therapies for numerous allergic reactions, including asthma. … |
View full post on asthma – Google News
 Myjoyonline.com |
Promising New Asthma Treatment Discovered by Chance
Big Think A potential new treatment for delayed asthma attacks—which can occur several hours after exposure to allergens—has been discovered by a team from Imperial College London. A delayed response—caused by allergens triggering sensory nerves in the … New treatments for asthma patients Asthma attack treatment 'find' Scientists Discover New Asthma Treatment Procedure |
View full post on asthma – Google News
HealthDay – WEDNESDAY, Aug. 3 (HealthDay News) — A new experimental drug for
adults with asthma seems to improve lung function in patients who haven’t
been helped with standard steroids.
View full post on Yahoo! News: Health News